141 related articles for article (PubMed ID: 29387556)
1. Pretreatment neutrophil-to-lymphocyte ratio predicts worse survival outcomes and advanced tumor staging in patients undergoing radical cystectomy for bladder cancer.
Tan YG; Eu E; Lau Kam On W; Huang HH
Asian J Urol; 2017 Oct; 4(4):239-246. PubMed ID: 29387556
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
[TBL] [Abstract][Full Text] [Related]
3. Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Hermanns T; Bhindi B; Wei Y; Yu J; Noon AP; Richard PO; Bhatt JR; Almatar A; Jewett MA; Fleshner NE; Zlotta AR; Templeton AJ; Kulkarni GS
Br J Cancer; 2014 Jul; 111(3):444-51. PubMed ID: 24918819
[TBL] [Abstract][Full Text] [Related]
4. The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysis.
Lucca I; Jichlinski P; Shariat SF; Rouprêt M; Rieken M; Kluth LA; Rink M; Mathieu R; Mbeutcha A; Maj-Hes A; Fajkovic H; Briganti A; Seitz C; Karakiewicz PI; de Martino M; Lotan Y; Babjuk M; Klatte T
Eur Urol Focus; 2016 Apr; 2(1):79-85. PubMed ID: 28723455
[TBL] [Abstract][Full Text] [Related]
5. High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer.
Tan YG; Eu EWC; Huang HH; Lau WKO
Int J Urol; 2018 Mar; 25(3):232-238. PubMed ID: 29094397
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Ann Surg Oncol; 2016 Jan; 23(1):335-42. PubMed ID: 26152275
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy.
D'Andrea D; Moschini M; Gust KM; Abufaraj M; Özsoy M; Mathieu R; Soria F; Briganti A; Rouprêt M; Karakiewicz PI; Shariat SF
J Surg Oncol; 2017 Mar; 115(4):455-461. PubMed ID: 28105663
[TBL] [Abstract][Full Text] [Related]
8. Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer.
Buisan O; Orsola A; Areal J; Font A; Oliveira M; Martinez R; Ibarz L
Clin Genitourin Cancer; 2017 Feb; 15(1):145-151.e2. PubMed ID: 27364982
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-to-lymphocyte ratio independently predicts advanced pathological staging and poorer survival outcomes in testicular cancer.
Tan YG; Sia J; Huang HH; Lau WKO
Investig Clin Urol; 2019 May; 60(3):176-183. PubMed ID: 31098425
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with urothelial carcinoma of the bladder following radical cystectomy.
Zattoni F; Novara G; Iafrate M; Carletti F; Reitano G; Randazzo G; Ceccato T; Betto G; Dal Moro F
Cent European J Urol; 2023; 76(2):90-103. PubMed ID: 37483852
[TBL] [Abstract][Full Text] [Related]
11. Can the Preoperative Neutrophil-to-Lymphocyte Ratio Significantly Predict the Conditional Survival Probability in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy?
Kang M; Balpukov UJ; Jeong CW; Kwak C; Kim HH; Ku JH
Clin Genitourin Cancer; 2017 Jun; 15(3):e411-e420. PubMed ID: 28162942
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-to-lymphocyte ratio as a detection marker of tumor recurrence in patients with muscle-invasive bladder cancer after radical cystectomy.
Morizawa Y; Miyake M; Shimada K; Hori S; Tatsumi Y; Nakai Y; Anai S; Tanaka N; Konishi N; Fujimoto K
Urol Oncol; 2016 Jun; 34(6):257.e11-7. PubMed ID: 27038696
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer.
Mano R; Baniel J; Shoshany O; Margel D; Bar-On T; Nativ O; Rubinstein J; Halachmi S
Urol Oncol; 2015 Feb; 33(2):67.e1-7. PubMed ID: 25060672
[TBL] [Abstract][Full Text] [Related]
14. Role of Inflammation in the Perioperative Management of Urothelial Bladder Cancer With Squamous-Cell Features: Impact of Neutrophil-to-Lymphocyte Ratio on Outcomes and Response to Neoadjuvant Chemotherapy.
Buisan O; Orsola A; Oliveira M; Martinez R; Etxaniz O; Areal J; Ibarz L
Clin Genitourin Cancer; 2017 Aug; 15(4):e697-e706. PubMed ID: 28274590
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy.
Black AJ; Zargar H; Zargar-Shoshtari K; Fairey AS; Mertens LS; Dinney CP; Mir MC; Krabbe LM; Cookson MS; Jacobsen NE; Griffin J; Montgomery JS; Vasdev N; Yu EY; Xylinas E; Campain NJ; Kassouf W; Dall'Era MA; Seah JA; Ercole CE; Horenblas S; McGrath JS; Aning J; Shariat SF; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; North S; Barocas DA; Lotan Y; Grivas P; Stephenson AJ; Shah JB; van Rhijn BW; Spiess PE; Daneshmand S; Sridhar SS; Black PC
Urol Oncol; 2020 Jan; 38(1):3.e17-3.e27. PubMed ID: 31676278
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study.
Peng D; Gong YQ; Hao H; He ZS; Li XS; Zhang CJ; Zhou LQ
BMC Cancer; 2017 Jun; 17(1):391. PubMed ID: 28578683
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy.
Hirasawa Y; Nakashima J; Yunaiyama D; Sugihara T; Gondo T; Nakagami Y; Horiguchi Y; Ohno Y; Namiki K; Ohori M; Tokuuye K; Tachibana M
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1048-1054. PubMed ID: 27699608
[TBL] [Abstract][Full Text] [Related]
18. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-lymphocyte ratio as a predictor of overall survival and cancer advancement in patients undergoing radical cystectomy for bladder cancer.
Sudoł D; Widz D; Mitura P; Płaza P; Godzisz M; Kuliniec I; Yadlos A; Cabanek M; Bar M; Bar K
Cent European J Urol; 2022; 75(1):41-46. PubMed ID: 35591971
[TBL] [Abstract][Full Text] [Related]
20. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis.
Bhindi B; Frank I; Mason RJ; Tarrell RF; Thapa P; Cheville JC; Costello BA; Pagliaro LC; Karnes RJ; Thompson RH; Tollefson MK; Boorjian SA
Eur Urol; 2017 Nov; 72(5):660-664. PubMed ID: 28545841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
